Cronos (CRON) Non-Current Assets (2016 - 2026)
Cronos (CRON) posted quarterly Non-Current Assets of $244.2 million for Q1 2026, up 3.82% year-over-year from $235.2 million in Q1 2025, and down 3.49% quarter-over-quarter from $253.1 million in Q4 2025.
Cronos (CRON) Non-Current Assets (2016 - 2026) Analysis & Trends
Cronos' Non-Current Assets history runs 11 years deep, the most recent figure standing at $244.2 million for Q1 2026.
- In Q1 2026, Non-Current Assets rose 3.82% year-over-year to $244.2 million; the TTM figure through Mar 2026 stood at $1.0 billion (up 18.37% YoY), while the FY2025 annual figure was $253.1 million, up 9.93% from the prior year.
- Non-Current Assets for Q1 2026 stood at $244.2 million, down from $253.1 million in the prior quarter.
- The five-year high for Non-Current Assets was $307.6 million in Q1 2022, with the low at $99.2 million in Q4 2023.
- The 5-year median for Non-Current Assets is $243.4 million (2023), against an average of $225.0 million.
- The sharpest annual moves came in 2022 and 2024: Non-Current Assets plunged 45.16% in 2022, then soared 131.99% in 2024.
- Cronos' Non-Current Assets stood at $104.2 million in 2022, then declined by 4.8% to $99.2 million in 2023, then jumped by 131.99% to $230.2 million in 2024, then rose by 9.93% to $253.1 million in 2025, then declined by 3.49% to $244.2 million in 2026.
- Business Quant data shows CRON's Non-Current Assets at $244.2 million in Q1 2026, $253.1 million in Q4 2025, and $256.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.96 Bn |
| 10 | Cronos | 1.20 Bn | 407.87 Mn | 28.45 Mn | 267.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 267.83 Mn |
| Mar 31, 2026 | 244.23 Mn |
| Dec 31, 2025 | 253.05 Mn |
| Sep 30, 2025 | 256.26 Mn |
| Jun 30, 2025 | 248.08 Mn |
| Mar 31, 2025 | 235.25 Mn |
| Dec 31, 2024 | 230.20 Mn |
| Sep 30, 2024 | 224.96 Mn |
| Jun 30, 2024 | 155.77 Mn |
| Mar 31, 2024 | 166.32 Mn |
| Dec 31, 2023 | 99.23 Mn |
| Sep 30, 2023 | 231.73 Mn |
| Jun 30, 2023 | 243.57 Mn |
| Mar 31, 2023 | 243.44 Mn |
| Dec 31, 2022 | 104.23 Mn |
| Sep 30, 2022 | 274.15 Mn |
| Jun 30, 2022 | 306.16 Mn |
| Mar 31, 2022 | 307.60 Mn |
| Dec 31, 2021 | 125.78 Mn |
| Sep 30, 2021 | 431.34 Mn |